Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia

Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia

Aristea-Maria Papanota,* Ioannis Ntanasis-Stathopoulos,* Efstathios Kastritis, Meletios A Dimopoulos, Maria GavriatopoulouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, GreeceCorrespondence: Maria Gavriatop...

Full description

Bibliographic Details
Main Authors: Papanota AM, Ntanasis-Stathopoulos I, Kastritis E, Dimopoulos MA, Gavriatopoulou M
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Journal of Blood Medicine
Subjects:
Waldenstrom’s macroglobulinemia
IgM
ibrutinib
Bruton’s tyrosine kinase
Online Access:https://www.dovepress.com/evaluating-ibrutinib-in-the-treatment-of-symptomatic-waldenstroms-macr-peer-reviewed-article-JBM

Internet

https://www.dovepress.com/evaluating-ibrutinib-in-the-treatment-of-symptomatic-waldenstroms-macr-peer-reviewed-article-JBM

Similar Items